Misty Shields

Dr. Misty Shields, a medical oncologist at Indiana University specializing in small cell lung cancer, shares her insights on managing side effects from new treatments. She discusses the latest advancements from ASCO 2025, focusing on the treatment algorithm for patients with good performance status. Key points include common side effects of lurbinectedin and immunotherapy, strategies for managing hematologic toxicities, and the crucial role of supportive and palliative care in improving patient quality of life. Collaboration between community oncologists and academic centers is emphasized for optimal care.